138 studies found for:    "Parkes Weber syndrome" OR "Vascular Malformations"
Show Display Options
Rank Status Study
1 Recruiting Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
2 Completed Diagnosis of Hemangiomas and Vascular Malformations
Conditions: Hemangiomas;   Vascular Malformations;   Venular Malformations;   Venous Malformations;   Lymphatic Malformations;   Arteriovenous Malformations
Intervention:
3 Recruiting French National Cohort of Children With Port Wine Stain
Conditions: Port Wine Stain;   Klippel Trenaunay Syndrome;   Parkes Weber Syndrome
Intervention: Genetic: search for polymorphisms of RASA1 gene
4 Recruiting Cryoablation of Venous Vascular Malformations
Condition: Venous Vascular Malformation
Intervention: Device: Percutaneous Image-guided Cryoablation (FPRPR3508 IceRod® PLUS Needles)
5 Not yet recruiting Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
Condition: Sturge Weber Syndrome
Intervention: Drug: Everolimus
6 Completed Use of the Atkins Diet for Children With Sturge Weber Syndrome
Conditions: Epilepsy;   Sturge Weber Syndrome
Intervention: Dietary Supplement: modified Atkins diet
7 Recruiting Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Conditions: Sturge Weber Syndrome;   Port Wine Mark
Interventions: Drug: Timolol;   Drug: Preservative free artificial tear gel.
8 Recruiting Safety of Apollo Micro Catheter in Pediatric Patients
Conditions: Brain Arteriovenous Malformation (AVM);   Brain Vascular Malformations;   Vein of Galen Malformation
Intervention: Device: Apollo Micro Catheter device
9 Completed Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome
Condition: Sturge- Weber Syndrome
Intervention: Drug: Drug: Topical Rapamycin
10 Completed Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)
Condition: Sturge - Weber Syndrome (SWS)
Intervention:
11 Completed Biomarker Development in Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
12 Active, not recruiting Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Conditions: Kaposiform Hemangioendotheliomas;   Tufted Angioma;   Capillary Venous Lymphatic Malformation;   Venous Lymphatic Malformation;   Microcystic Lymphatic Malformation;   Mucocutaneous Lymphangiomatosis and Thrombocytopenia;   Capillary Lymphatic Arterial Venous Malformations;   PTEN Overgrowth Syndrome With Vascular Anomaly;   Lymphangiectasia Syndromes
Intervention: Drug: sirolimus
13 Recruiting Registry for Vascular Anomalies Associated With Coagulopathy
Conditions: Multifocal Lymphangioendotheliomatosis With Thrombocytopenia;   Cutaneovisceral Angiomatosis With Thrombocytopenia;   Vascular Anomaly With Thrombocytopenia;   Hemangiomas
Intervention: Other: no intervention
14 Completed Vascular Malformations and Abnormalities of Growth
Condition: Abnormality
Intervention: Procedure: skin biopsy
15 Enrolling by invitation The Management of Postoperative Craniotomy Pain in Pediatric Patients
Conditions: Post Craniotomy Surgery;   Cancer;   Epilepsy;   Vascular Malformations;   Craniofacial Reconstructive Surgery
Intervention:
16 Completed
Has Results
Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation
Conditions: Obscure Gastrointestinal Bleeding;   Angiodysplasia;   Gastric Antral Vascular Ectasia;   Thalidomide
Interventions: Drug: Thalidomide;   Drug: Iron
17 Recruiting Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Condition: Cardiovascular Abnormalities
Intervention: Drug: Sirolimus
18 Recruiting Genetic Basis of Hemangiomas
Condition: Hemangioma, Vascular Anomalies
Interventions: Genetic: Cheek cell samples or blood sample (4mL);   Genetic: Cheek cell sample or blood sample (4mL)
19 Completed Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab
20 Completed Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
Condition: Vascular Anomalies
Intervention: Drug: Marimastat

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years